M3V.DE
Mevis Medical Solutions AG
Price:  
25.8 
EUR
Volume:  
78
Germany | Health Care Technology

M3V.DE WACC - Weighted Average Cost of Capital

The WACC of Mevis Medical Solutions AG (M3V.DE) is 6.8%.

The Cost of Equity of Mevis Medical Solutions AG (M3V.DE) is 9.4%.
The Cost of Debt of Mevis Medical Solutions AG (M3V.DE) is 4.25%.

RangeSelected
Cost of equity7.5% - 11.3%9.4%
Tax rate1.4% - 1.7%1.55%
Cost of debt4.0% - 4.5%4.25%
WACC5.7% - 7.9%6.8%
WACC

M3V.DE WACC calculation

CategoryLowHigh
Long-term bond rate2.0%2.5%
Equity market risk premium4.7%5.7%
Adjusted beta1.151.45
Additional risk adjustments0.0%0.5%
Cost of equity7.5%11.3%
Tax rate1.4%1.7%
Debt/Equity ratio
11
Cost of debt4.0%4.5%
After-tax WACC5.7%7.9%
Selected WACC6.8%

M3V.DE's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for M3V.DE:

cost_of_equity (9.40%) = risk_free_rate (2.25%) + equity_risk_premium (5.20%) * adjusted_beta (1.15) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.